Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Pharmaceutical Excipients Global Market - Forecast to 2025

Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability, and stability of active substances for formulating final drug dosage forms.


News provided by

Reportlinker

Aug 26, 2019, 06:38 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Aug. 26, 2019 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p04155351/?utm_source=PRN 

The excipients form the major part in any medicinal product and proportion of it when compared to Active Pharmaceutical Ingredient (API) exceeds two to three folds in any pharmaceutical preparations. Hence, various characteristics such as functionality, regulatory status, sources, cost, consistency, bioavailability, physicochemical properties, stability, and pharmacokinetic parameters, etc. play a major role in determining the suitability of a substance as an excipient.

As estimated by IQ4I Research, the pharmaceutical excipients global market is expected to grow at a single digit CAGR from 2018 to 2025 to reach $9,911.2 million by 2025. The pharmaceutical excipients market is segmented by source, products, process, functionality, drug dosage forms and finished products.

Pharmaceutical excipients market by the source is segmented as animal-based, plant-based, mineral-based and synthetic based excipients. Plant-based excipients held the highest revenue in 2018 and it is a fastest growing segment at a high single digit CAGR from 2018 to 2025, due to plant-based excipients are cost-effective, low toxic with the better patient tolerance, bio-compatible and they are easily available. By-products, excipients are segmented into inorganic chemicals, organic chemicals and pharmaceutical water. The organic chemicals segment held the highest revenue in 2018 and it is expected to grow at a single digit CAGR from 2018 to 2025, due to the use of these excipients in majorly all of the pharmaceutical formulations as they offer advantages such as increased efficacy in oral delivery of poorly soluble molecules along with increased compressibility and flowability properties.

Inorganic chemical excipients market by type, are further divided into calcium salts, halites, metallic oxides, silicates, and other inorganic chemicals, among which metallic oxides held a major revenue in 2018 and Calcium salts segment is expected to grow at a high single digit CAGR from 2018 to 2025. Calcium salts are further sub-segmented into calcium phosphate and calcium carbonate, among which calcium phosphate held the highest revenue in 2018 and calcium carbonate segment is expected to grow at a high single digit CAGR from 2018 to 2025. Calcium carbonate is further classified into GCC and PCC, among which PCC held the highest revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025. Metallic oxides segment are further segmented into titanium dioxide and Others (Iron Oxide, Magnesium Oxide & Aluminum Hydroxide). Titanium Dioxide held the highest revenue in 2018 and it is expected to grow at a mid single digit CAGR from 2018 to 2025.

Organic chemical excipients market by type is further divided into carbohydrates, petrochemicals, oleochemicals, proteins, and other organic chemicals. Oleochemicals held major revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025.

Carbohydrate excipients market by type is further segmented into sugar, starch, and cellulose, among which sugar held the largest revenue in 2018 and expected to grow at a mid single digit CAGR from 2018 to 2025. Sugar segment is further divided into actual sugar, sugar alcohol, and artificial sweeteners, where actual sugar held the largest revenue in 2018 and sugar alcohol segment is expected to grow at a mid single digit CAGR from 2018 to 2025.

Actual sugar segment is further sub-segmented into lactose, sucrose, and dextrose, where lactose held the largest revenue in 2018 and dextrose segment is expected to grow at a mid single digit CAGR from 2018 to 2025. Sugar alcohol segment is further classified into sorbitol, mannitol and other sugar alcohols, where mannitol held the largest revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025. The starch segment is further divided into modified starch, dried starch and converted starch, where modified starch held the largest revenue in 2018 and dried starch is expected to grow at a mid single digit CAGR from 2018 to 2025. Cellulose segment is further sub-segmented into cellulose ethers, cellulose esters, croscarmellose sodium, and microcrystalline cellulose, where cellulose ethers held the largest revenue in 2018 and microcrystalline cellulose is expected to grow at a mid single digit CAGR from 2018 to 2025.

Petrochemical excipients market by type is further segmented into glycols, povidones, mineral hydrocarbons, acrylic polymers, and other petrochemical excipients. Glycol held the largest revenue in 2018 and acrylic polymers is expected to grow at a high single digit CAGR from 2018 to 2025. Glycol segment is further segmented into Polyethylene Glycol and Propylene Glycol, where Polyethylene Glycol held the largest revenue in 2018 it is expected to grow at a mid single digit CAGR from 2018 to 2025.

Oleochemicals excipients market by type is further segmented into Fatty Alcohols, Metal stearates, Glycerin, and Other Oleochemical Excipients. Fatty Alcohol held the largest revenue in 2018 and Metal stearates is expected to grow at a high single digit CAGR from 2018 to 2025.

Pharma/USP water excipients market by type is further segment into the water for injections and purified water. Water for injections held the largest revenue in 2018 and it is expected to grow at a mid single digit CAGR from 2018 to 2025. Pharmaceutical excipients market by the process is segmented as granulation and direct compression. Granulation held the largest revenue in 2018 and direct compression is expected to grow at a high single digit CAGR from 2018 to 2025.

Pharmaceutical excipients market by functionality is segmented as preservatives, solvent, binders & adhesives, fillers & diluents, suspending agent, coatings, solubilizer, disintegrant, colorant, flavoring & sweeteners, lubricants & glidants, and others. Binders & Adhesives held the largest revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025.

Pharmaceutical excipients market by dosage forms is segmented as solid dosage forms, injectables and semisolid, liquid and gaseous. Solid dosage forms held the largest revenue in 2018 and it is expected to grow at a high single digit CAGR from 2018 to 2025. Some of the factors driving the market are solid dosage forms are cost-effective, solid dosage provides increased physical and chemical stability, controlled-release options, and superior ease of handling.

Pharmaceutical excipients market by finished products is segmented as Prescription drugs and OTC. Prescription drugs held the largest revenue in 2018 and it is expected to grow at a mid single digit CAGR from 2018 to 2025.

Pharmaceutical excipients market by region is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Rest of Europe), Asia-Pacific (China, India, Japan, and Others) and Rest of the world (Brazil, Rest of Latin America and Middle East & others). North America held the highest revenue in 2018, due to increasing demand for functional excipients, implementation of new novelties like nanotechnology, increasing usage of oral solid dosage forms, increasing incidence of chronic disorders, elderly population and favorable reimbursement scenario for drugs. Asia-Pacific is the fastest growing region with a high single digit CAGR from 2018 to 2025, due to increasing excipients outsourcing by companies, low manufacturing, and low labor costs, adopting modern innovations like nanotechnology, advancement in the development of functional excipients, rise in chronic diseases, growing generics market owing to patent cliffs, rising healthcare demand, better infrastructure, lower capital, and overhead costs. Excipients manufacturers in developing countries face major challenges to develop product with quality at an affordable price, due to lower price of excipients and large number of producers, which creates a price sensitive market. Some manufacturers may compromise the quality of product in order to keep prices low and boost sales, while some of the manufacturers having a larger market for their products, can sell their higher volume excipients at a slightly lower price.

Some of the key players contributing at global level for pharmaceutical excipients market growth are Dow DuPont (U.S.), Ashland, Inc. (U.S.), BASF SE (Germany), DFE Pharma (Germany), Evonik Industries AG (Germany), Associated British Foods Plc (U.K.), Merck KGAA (U.S.), Roquette (France), Colorcon (U.S.), and Asahi Kasei (Japan).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America

o U.S.

o Rest of North America

• Europeo Germanyo Franceo Italyo Rest of Europe

• Asia-Pacific

o China

o India

o Japan

o Rest of APAC

• Rest of the World (RoW)o Brazilo Rest of Latin Americao Middle East and Others

Read the full report: https://www.reportlinker.com/p04155351/?utm_source=PRN

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Contact Clare: [email protected]

US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.